Organogenesis Holdings, Inc. (ORGO)
2.24
-0.07
(-3.03%)
USD |
NASDAQ |
Apr 02, 16:00
2.24
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Market Cap : 280.05M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.764B |
| Alnylam Pharmaceuticals, Inc. | 40.99B |
| Savara, Inc. | 1.133B |
| BioMarin Pharmaceutical, Inc. | 10.35B |
| Imunon, Inc. | 7.404M |
Market Cap Related Metrics
| PE Ratio | 20.46 |
| PS Ratio | 0.5124 |
| PEG Ratio | 0.0112 |
| Price to Book Value | 0.9601 |
| Price | 2.24 |
| Earnings Yield | 4.89% |
| PEGY Ratio | 0.0112 |
| Operating PE Ratio | 5.088 |
| Normalized PE Ratio | 12.73 |